Aldose reductase-IN-7
Aldose reductase-IN-7 (Compound 6k) targets Aldose reductase. Aldose reductase-IN-7 exhibits potent enzyme inhibitory activity (Ki = 0.186 ± 0.020 μM), showing superiority to Epalrestat (HY-66009), which is currently in clinical use. Aldose reductase-IN-7 is less cytotoxic and possesses potent anticancer activity.
For research use only. We do not sell to patients.
- Formula: C21H20N4O7
- Molecular Weight:440.41
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Aldose reductase-IN-7 (24 h) shows low cytotoxicity in L929 cells (IC50 = 569.58 ± 0.80 μM). Significant anticancer activity can be observed in MCF-7 cells (IC50 = 110.87 ± 0.42 μM)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:L929 cells and MCF-7 cells
-
Concentration:
-
Incubation Time:24h
-
Result:Ideally, killed cancer cells without harming healthy cells (SI value of 5.13). Specifically inhibited the proliferation of cancer cells compared to non-cancerous cells.
Chemical Information
-
Molecular Weight 440.41
-
Formula C21H20N4O7
-
SMILES
O=C(OCC)CN(C1=CC=C([N+]([O-])=O)C=C1C23OC(CC4=CC=C(OC)C=C4)=NN3)C2=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)